Experiments show that transferring a cancer cell's dysfunctional mitochondria—but not its nucleus—into a healthy cell is what induces cancer. This disruptive finding supports the view of cancer as a metabolic disease that can be targeted by starving its mitochondria of fuels like glucose.

The company's buffering agent is naturally drawn to the most acidic areas of the body. Since tumors actively export acid, they create a "magnet" for the therapy. This approach leverages basic chemical kinetics for targeting, bypassing the need for complex biological receptors and acting as an upstream solution.

The company's core technology was first used to buffer lactic acidosis for athletic performance. After proving they could effectively modulate pH, they asked "where does pH matter most biologically?" This led them to the long-understood but hard-to-drug problem of the acidic tumor microenvironment, a much larger market.

Aggressive treatments like radiation and chemotherapy induce immense metabolic stress, causing blood sugar to spike. This pushes the patient's body into a metabolic "red zone," which can create an environment that strengthens and feeds any remaining resistant tumor cells.

Chemotherapy is known to worsen metabolic parameters, but this should be viewed as an opportunity, not just a side effect. By actively correcting this metabolic dysfunction with adjunctive therapies, clinicians may be able to enhance the overall life-saving benefit of the chemotherapy itself.

Cancer should be viewed not just as rogue cells, but as a complex system with its own supply chains and communication infrastructure. This perspective shift justifies novel therapies like Zelenorstat, which aim to dismantle this entire operating system by cutting its power source.

While most immuno-oncology drugs target specific cellular pathways, Dive Biosciences targets the acidic tumor microenvironment itself. This is framed as a foundational "upstream checkpoint" that degrades the entire immune "ecology," suppressing every type of immune cell in the tumor's vicinity at once, rather than one receptor at a time.

The origin of cancer is damage to the mitochondria, the cell's powerhouses. This impairs energy production, forcing cells into a primitive state of uncontrolled growth. Genetic mutations are a downstream effect, not the primary cause.

The Warburg effect isn't caused by broken mitochondria in cancer cells. Instead, their mitochondria are highly functional but have been reprogrammed to shunt resources away from energy production (burning) towards creating the biomass needed for rapid tumor growth.